An update of the recommendations of the spanish neonatology society for the use of paivizumab as prophylaxis for severe infections due to syncytial respiratory virus in high risk infants

• Manuel Sánchez Luna,
• Alejandro Pérez Muñuzuri,
• José Luis Leante Castellanos,
• César W. Ruiz Campillo,
• Ester Sanz López,
• Isabel Benavente Fernández,
• María Dolores Sánchez Redondo,
• Segundo Rite Gracia

Affiliations

Manuel Sánchez Luna

Hospital General Universitario Gregorio Marañón, Madrid, Spain

Alejandro Pérez Muñuzuri

Hospital Clínico Universitario, Santiago de Compostela, Spain

José Luis Leante Castellanos

Hospital General Universitario Santa Lucía, Cartagena, Spain

César W. Ruiz Campillo

Hospital Universitario Vall d’Hebron, Barcelona, Spain

Ester Sanz López

Hospital General Universitario Gregorio Marañón, Madrid, Spain

Isabel Benavente Fernández

Hospital Universitario Puerta del Mar, Cádiz, Spain

María Dolores Sánchez Redondo

Hospital Virgen de la Salud, Complejo Hospitalario de Toledo, Toledo, Spain

Segundo Rite Gracia

Corresponding autor.; Hospital Universitario Miguel Servet, Zaragoza, Spain